Escitalopram Oxalate Tablet is the generic version of Forest Laboratories’ depression and generalized anxiety disorder treatment tablets.
Teva has received a 180-day period of marketing exclusivity as it is the first company to file an abbreviated new drug application(ANDA) containing a paragraph IV certification for the product.
The brand product had annual sales of approximately $2.9bn in the US, based on IMS sales data.
Â